首页> 外文期刊>Indian Journal of Medical Microbiology >Detection of rifampicin resistance in tuberculosis by molecular methods: A report from Eastern Uttar Pradesh, India
【24h】

Detection of rifampicin resistance in tuberculosis by molecular methods: A report from Eastern Uttar Pradesh, India

机译:分子方法检测结核病中的利福平耐药性:印度东部北方邦的报告

获取原文
           

摘要

Diagnosis of drug resistance tuberculosis (TB) by the gold standard method is labour intensive and time consuming. Hence, there is an urgent need for introduction of rapid diagnostic techniques. Line probe assay (LPA) and cartridge-based nucleic acid amplification test (CBNAAT) have been introduced in India under Revised National Tuberculosis Control Program. Spot and morning sputum samples of previously treated patients by anti-TB drugs were subjected to LPA or CBNAAT. Total 682/1253 (54.4%) were diagnosed as rifampicin-resistant. The patients could be diagnosed early by molecular methods and put on second line treatment.
机译:用金标准方法诊断抗药性结核病(TB)是费力且费时的。因此,迫切需要引入快速诊断技术。根据修订的《国家结核病控制计划》,线探针测定法(LPA)和基于盒的核酸扩增测试(CBNAAT)已在印度引入。对先前接受过抗结核药物治疗的患者的痰标本和晨痰标本进行LPA或CBNAAT。总计682/1253(54.4%)被诊断为耐利福平。可以通过分子方法及早诊断出患者并进行二线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号